SEVEN EIGHT CAPITAL, LP - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q2 2020$374,000
-94.6%
2,200
-96.4%
0.27%
-25.7%
Q4 2019$6,957,000
+182.1%
60,889
+110.9%
0.37%
+183.8%
Q3 2019$2,466,000
+535.6%
28,875
+473.4%
0.13%
+441.7%
Q3 2018$388,000
+99.0%
5,036
-1.3%
0.02%
-87.2%
Q2 2014$195,000
-44.4%
5,100
-42.0%
0.19%
-51.8%
Q4 2013$351,0008,8000.39%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders